| Authors: |
Arellano ML; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University School of Medicine, Atlanta, GA., Thirman MJ; Department of Medicine, Section of Hematology and Oncology, The University of Chicago Medicine, Chicago, IL., DiPersio JF; Department of Medicine, Washington University School of Medicine, St Louis, MO., Heiblig M; Hematology Department, Centre Hospitalier Lyon Sud, Lyon, France., Stein EM; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Schuh AC; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada., Žučenka A; Faculty of Medicine, Hematology and Oncology Department, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania., de Botton S; Hematologie Clinique, Institut Gustave Roussy, Villejuif, France., Grove CS; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.; Department of Haematology, PathWest Inc, Nedlands, WA, Australia.; Department of Haematology, University of Western Australia, Nedlands, WA, Australia., Mannis GN; Division of Hematology, Stanford University School of Medicine, Stanford, CA., Papayannidis C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli,' Bologna, Italy., Perl AE; Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Bajel A; Department of Haematology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.; Department of Haematology, The Royal Melbourne Hospital, Melbourne, VIC, Australia., Dickens DS; Division of Pediatric Hematology/Oncology, University of Iowa Stead Family Children's Hospital, Iowa City, IA., Kühn MWM; Department of Hematology and Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany., Mantzaris I; Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY., Raffoux E; Adult Hematology Department, Hospital Saint Louis, Université Paris Diderot, Paris, France., Traer E; Division of Hematology/Medical Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR., Amitai I; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel.; School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Döhner H; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Greco C; Division of Hematology, Ospedale San Bortolo, Aulss Berica, Vicenza, Italy., Kovacsovics T; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Phoenix, Goodyear, AZ., McMahon CM; Department of Hematology, University of Colorado School of Medicine, Aurora, CO., Montesinos P; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Pigneux A; Hematology Department, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France., Shami PJ; Division of Hematology and Hematologic Malignancies, University of Utah Huntsman Cancer Institute, Salt Lake City, UT., Stone RM; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA., Wolach O; School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel., Harpel JG; ICON plc, New York, NY., Chudnovsky Y; Syndax Pharmaceuticals, Inc, Waltham, MA., Yu L; Syndax Pharmaceuticals, Inc, Waltham, MA., Bagley RG; Syndax Pharmaceuticals, Inc, Waltham, MA., Smith AR; Syndax Pharmaceuticals, Inc, Waltham, MA., Blachly JS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH. |
